Magnetic resonance imaging scanners work by detecting various points in a patient's body and building a 2-dimensional or 3-dimensional image of the body. The image is created using magnetic imaging and radio waves. 

MRIs are a very useful diagnositc tool for doctors because they provide doctors with extraordinary detail of the body's tissues. Doctors can use this tissue to determine if there are tissue abnormalities or if the blood is not flowing properly in some part of the body. 

In some cases, doctors will use a contrasting agent to refine the image. Some of these agents, however, have been linked to cancer and other side effects.

If you or anyone you know has experienced adverse side effects resulting from a gadolinium-based agent, contact the gadolinium lawyers of Williams Kherker at 800-761-3187. 

According to a recent article in Business Week, General Electric is facing a growing number of concerns about Omniscan. The gadolinium-based drug is used in MRI scans and may be linked to nephrogenic systemic fibrosis (NSF). 

Omniscan is one of a number of similar products that is being tied to kidney disease in some patients. According to the article, GE has 30% of the drug market, while Bayer HealthCare has 50% of the market. 

If some of the cases against GE force the company to compensate victims for their injuries related to Omniscan, then the verdicts could hurt the company's growing health-care division. 

If you or anyone you know has sustained injuries after undergoing an MRI scan with a gadolinium-based agent, contact the gadolinium lawyers of Williams Kherkher at 800-761-3187. 

The FDA has released its list of drugs that are being reviewed for safety problems. These drugs include gadolinium-based contrast agents, which are used during magnetic resonance imaging. 

The FDA is investigating these drugs for potential links to anaphylaxis hypersensitivity. The drugs have already been linked to Nephrogenic Systemic Fibrosis and Nephrogenic Fibrosing Dermopathy. 

If you or anyone you know has received a gadolinium-based contrast agent, contact the NSF and NFD lawyers of Williams Kherkher at 800-761-3187.

While the Food and Drug Administration (FDA) identified a link between gadolinium-based contrast agents and nephrogenic systemic fibrosis, the FDA has taken very few actions to prevent the use of the contrast agent in MRI scans. 

Because these contrast agents are still used in some MRI scans, it is important to be able to identify when gadolinium-based contrast agents are used in MRIs. The five most common types of these contrast agents are Magnevist, MultiHance, Omniscan, OptiMARK, and Prohance.

If you have received an MRI with a gadolinium-based contrast agent, contact the NSF and NSD lawyers of Williams Kherkher at 800-761-3187.